Skip to main content

Abbreviated Breast MRI Has High Diagnostic Accuracy for Dense Breasts

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on May 22, 2025.

via HealthDay

THURSDAY, May 22, 2025 -- For women with extremely dense breasts who are negative for cancer at mammography, abbreviated breast magnetic resonance imaging (MRI) for first-round screening has high diagnostic accuracy, comparable to the full multiparametric protocol, according to a study published online May 20 in Radiology.

Sophie E.L. van Grinsven, Ph.D., from Utrecht University in the Netherlands, and colleagues compared multireader diagnostic accuracy of various abbreviated screening breast MRI protocols to that of the full multiparametric protocol in a secondary analysis of the Dense Tissue and Early Breast Neoplasm Screening trial. Seven radiologists performed incremental readings of first-round screening MRI scans in women with extremely dense breasts and negative findings for cancer at mammography. Different sequences were added in four incremental steps.

The first-round screening included 518 MRI scans, with 83 breast cancers: 68 invasive cancers and 15 ductal carcinomas in situ. The researchers found no evidence for a difference in sensitivity between the abbreviated protocol and full multiparametric MRI protocol (84.3 and 85.9 percent, respectively). No evidence was seen for a difference in specificity between the abbreviated protocol and full protocol (73.9 versus 75.8 percent). The pooled reading time was almost 50 percent shorter for the abbreviated versus the full protocol (49.7 versus 96.4 seconds), with 70 to 80 percent shorter scanning time, depending on the scanner vendor and hospital.

"Shorter reading and scan times may allow implementation of MRI in national screening programs, making it available for all women with extremely dense breasts," coauthor Wouter B. Veldhuis, M.D., Ph.D., also from Utrecht University, said in a statement.

Several authors disclosed ties to the biopharmaceutical and publishing industries.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Breast Cancer Incidence Trends Vary by Age

TUESDAY, July 1, 2025 -- Breast cancer incidence trends differ by age, even among older women, particularly by race and ethnicity and stage at diagnosis, according to a study...

Lower Risk of Alzheimer Disease Seen for Breast Cancer Survivors

MONDAY, June 30, 2025 -- Breast cancer survivors have a lower risk of Alzheimer disease (AD) compared with cancer-free controls, according to a study published online June 20 in...

CT Perfusion and CT Angiography Not Useful as Standalone Tests for Establishing Death by Neurologic Criteria

THURDAY, June 26, 2025 -- Neither computed tomography (CT) perfusion nor CT angiography meet the prespecified validation threshold as an ancillary test for death by neurologic...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.